中国临床药理学杂志2024,Vol.40Issue(16) :2383-2387.DOI:10.13699/j.cnki.1001-6821.2024.16.017

西洛他唑片在中国健康受试者中的生物等效性研究

Bioequivalence study of cilostazol tablets in Chinese healthy subjects

王彦荣 裴莹子 陈然 王莹 解明月
中国临床药理学杂志2024,Vol.40Issue(16) :2383-2387.DOI:10.13699/j.cnki.1001-6821.2024.16.017

西洛他唑片在中国健康受试者中的生物等效性研究

Bioequivalence study of cilostazol tablets in Chinese healthy subjects

王彦荣 1裴莹子 2陈然 1王莹 1解明月2
扫码查看

作者信息

  • 1. 沧州市中心医院药物临床试验机构办公室,河北沧州 061017
  • 2. 北京福元医药股份有限公司,北京 101113
  • 折叠

摘要

目的 评估2种西洛他唑片50 mg在中国健康受试者中的生物等效性及安全性.方法 本研究用开放、随机、双周期、双交叉、空腹给药的设计,共纳入32例健康成年受试者,分别单次口服西洛他唑片受试制剂或参比制剂50 mg.用液相色谱-质谱(LC-MS/MS)法测定血浆中西洛他唑的浓度,用SAS 9.4处理血浆中西洛他唑的浓度-时间数据,用非房室模型法计算西洛他唑的药代动力学参数,并进行生物等效性及安全性评价.结果 受试制剂和参比制剂的西洛他唑 Cmax 分别为(358.10±125.80)和(346.90±115.30)ng·mL-1,tmax分别为 3.50 和4.00 h,t1/2分别为(9.63±7.12)和(8.57±5.15)h,AUC0-t分别为(5 235.00±2 268.00)和(5 190.00±1 747.00)h·ng·mL-1,AUC0-∞ 分别为(5 377.00±2 367.00)和(5 308.00±1 848.00)h·ng·mL-1.受试制剂和参比制剂主要药代动力学参数的几何均值比值的90%置信区间均落在80.00%~125.00%.结论 中国健康受试者单次口服受试和参比西洛他唑片具有生物等效性,且安全性良好.

Abstract

Objective To evaluate the bioequivalence and safety of two cilostazol tablets 50 mg in healthy Chinese subjects.Methods This study was an open-lable,randomized,two-period crossover design.A total of 32 subjects respectively for fasting state were given a single oral dose of test or reference tedizolid phosphate tablets 50 mg.The plasma concentration of cilostazol was determined by liquid chromatography tandem mass spectrometry(LC-MS/MS),and the concentration-time data was processed by SAS 9.4,the model method of the non-compartmental was used to calculate the pharmacokinetic parameters of tedizolid and to evaluate the bioequivalence.Results The Cmax of cilostazol test and reference were(358.10±125.80)and(346.90±115.30)ng·mL-1;tmax were 3.50 and 4.00 h;t1/2 were(9.63±7.12)and(8.57±5.15)h;AUC0_twere(5 235.00±2 268.00)and(5 190.00±1 747.00)h·ng·mL-1;AUC0-∞ were(5 377.00±2 367.00)and(5 308.00±1 848.00)h·ng·mL-1.The 90%confidence intervals of the geometric mean ratios of the main pharmacokinetic parameters of the test drug and reference drug were within the range of 80.00%to 125.00%.Conclusion Single oral test and reference cilostazol tablets were bioequivalent and safe in healthy Chinese subjects.

关键词

西洛他唑片/健康受试者/生物等效性/药代动力学/液相色谱-质谱法

Key words

cilostazol tablet/healthy volunteers/bioequivalence/pharmacokinetics/liquid chromatography tandem mass spectrometry

引用本文复制引用

出版年

2024
中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCDCSCD北大核心
影响因子:1.91
ISSN:1001-6821
参考文献量6
段落导航相关论文